|
FREE patent keyword monitoring and additional FREE benefits. |
![]() |
|
|
USPTO Class 536 | Browse by Industry: Previous - Next | All 08/2006 | Recent | 09: Oct | Sept | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 08: Dec | Nov | Oct | Sp | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 07: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 06: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Organic compounds -- part of the class 532-570 series inventions 08/06Recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.Listing format for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 08/31/2006 > 2 patent applications in 1 patent subcategories. 20060194958 - Sequence-determined dna fragments encoding an1-like zinc finger proteins: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination... 20060194959 - Sequence-determined dna fragments encoding srf-type transcription factors: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination... 08/24/2006 > 4 patent applications in 4 patent subcategories.20060189798 - Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor: A previously isolated hepatitis B virus (HBV) integration in a 147 bp cellular DNA fragment linked to hepatocellular carcinoma (HCC) was used as a probe to clone the corresponding complementary DNA from a human liver cDNA library. Nucleotide sequence analysis revealed that the overall structure of the cellular gene, which... 20060189799 - Method of preventing modification of synthetic oligonucleotides: The present invention relates to a method of preventing modification of a synthetic oligonucleotide or oligonucleotide analog during removal of at least one cyanoethyl protecting group from the oligonucleotide or oligonucleotide analog. The method involves contacting the oligonucleotide or oligonucleotide analog with a basic solution having at least one acrylonitrile... 20060189800 - Indolopyrrolocabazole derivative and antitumor agent: e 20060189801 - Hydrophobic starch having near-neutral dry product ph: A free-flowing, hydrophobic starch composition has a near-neutral dry product pH. Methods for making the hydrophobic starch composition by preparing an aqueous mixture comprising a starch, a siliconate, and an acid, where the aqueous mixture has a near-neutral pH, and drying the starch solids to obtain a hydrophobic starch. Novel... 08/17/2006 > 6 patent applications in 4 patent subcategories.20060183890 - Isopropanolate of azithromycin and method of manufacturing: Azithromycin isopropanolate of the empirical formula azithromycin:[H20]x:[isopropanol]y is obtained from the crystallization of azithromycin in isopropanol and water. The x and y values is confirmed by single X-ray diffraction determination. In one embodiment x=1.5 and y=0.25. In another embodiment x=0.75 and y=0.5.... 20060183891 - Delta 4,5 glycuronidase nucleic acid compositions: The invention relates to Δ4,5 glycuronidase, related compositions, and methods of use thereof.... 20060183892 - Dna for encoding d-hydantoin hydrolases, dna for encoding n-carbamyl-d-amino acid hydrolases, recombinant dna containing the genes, cells transformed with the recombinant dna, methods for producing proteins utilizing the transformed cells and methods for: DNA for encoding a protein having D-hydantoinase activity which has a base sequence represented by Sequence ID No. 1 in the Sequence Listing. DNA for encoding a protein having D-carbamylase activity which has a base sequence represented by Sequence ID No. 3 in the Sequence Listing.... 20060183893 - Nucleic acids for apoptosis of cancer cells: The disclosure relates to a nucleic acid having an Apoptotic Sequence of: Seq. ID. No:1, Seq. ID. No:2, Seq. ID. No:3, Seq. ID. No:4, Seq. ID. No: 5, Seq. ID. No:6, and Seq. ID. No:7. It also relates to a compsoition including a nucleic acid having an Apoptotic Sequence of... 20060183894 - Synthetic dna encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors: Synthetic versions of a full length and termini truncated humanized green fluorescent protein based on Ptilosarcus gurneyi are disclosed which have been modified to the favored or most favored codons for mammalian expression systems. The disclosed encoded protein has 239 amino acid residues compared with the wild type Ptilosarcus gurneyi... 20060183895 - Materials and methods for the modification of plant lignin content: Novel isolated polynucleotides and polypeptides associated with the lignin biosynthetic pathway are provided, together with genetic constructs including such sequences. Methods for the modulation of lignin content, lignin structure and lignin composition in target organisms are also disclosed, the methods comprising incorporating one or more of the polynucleotides of the... 08/10/2006 > 4 patent applications in 4 patent subcategories.08/03/2006 > 3 patent applications in 3 patent subcategories. 20060173172 - Method for producing novel spinosyn derivatives: The present invention relates to methods for producing novel spinosyn derivatives which are substituted with a 1-hydroxy-ethyl radical in the C-21 position and to novel spinosyn derivatives of this type per se and to their use for producing novel spinosyns.... 20060173173 - 2' -0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same: of the ribonucleoside derivatives is: wherein R1 is a base of the purine- or pyrimidine-family or a derivative of such a base or any other residue with serves as a nucleobase surrogate, R2 is a proton or a substituted derivative of phosphonic acid, R3 is a proton or a protection-group... 20060173174 - Difluoronucleosides and process for preparation thereof: A stereoselective process for the preparation of a 2′,2′-difluronucleoside is provided. In the process, a protected 2′2′-difluorofuranose is coupled with a base selected from the group consisting of pyrimidine and purine derivatives in the presence of a Lewis acid, wherein the protected 2′2′-difluorofuranose has a 1-position leaving group and 3-... Previous industry: Organic compounds -- part of the class 532-570 seriesNext industry: Organic compounds -- part of the class 532-570 series ###### RSS FEED for 20091119: Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates. For more info, read this article. ###### Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email. ### FreshPatents.com Support Results in 0.30493 seconds |
* Easy, fast online form * Protect your Inventions * US Patent Office filing Provisional Patent Utility Patent - - - - - - - - - - - - - - - - - - - - - - * Fast online form * Protect your Name/Design * US Government filing Trademark Services - - - - - - - - - - - - - - - - - - - - - - PATENT INFO |